MAP2K7 and neoplasm: Upregulation of HSP70 helps tumors evade antitumor therapy by activating the RAF/MEK/ERK signaling pathway. In addition, HSP70 promotes cytoplasmic segregation of TP53 and negatively regulates its tumor suppressor function.